Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | TK2 |
| Upstream (Parents) |
|---|
| (<<) CASP4 → TK2 |
| (<<) CHST12 → TK2 |
| (<<) GAPDH → TK2 |
| (<<) ITGB5 → TK2 |
| (<<) ITGB8 → TK2 |
| (<<) MAP3K7 → TK2 |
| (<<) MN1 → TK2 |
| (<<) MOBKL2C → TK2 |
| (<<) NBL1 → TK2 |
| (<<) PCDH7 → TK2 |
| (<<) PGK1 → TK2 |
| (<<) PRKCH → TK2 |
| (<<) PTPN11 → TK2 |
| (<<) TAGLN2 → TK2 |
| (<<) THOC4 → TK2 |
| Downstream (Children) |
|---|
| TK2 → ABCF1 (>>) |
| TK2 → BCL3 (>>) |
| TK2 → BPGM (>>) |
| TK2 → CASP9 (>>) |
| TK2 → CCDC3 (>>) |
| TK2 → CD3EAP (>>) |
| TK2 → CXCL14 (>>) |
| TK2 → CYB561D1 (>>) |
| TK2 → CYP2U1 (>>) |
| TK2 → FGFR3 (>>) |
| TK2 → HOPX (>>) |
| TK2 → ITPR3 (>>) |
| TK2 → LIG1 (>>) |
| TK2 → MAPK11 (>>) |
| TK2 → MEF2D (>>) |
| TK2 → MMP28 (>>) |
| TK2 → NFATC4 (>>) |
| TK2 → NOL9 (>>) |
| TK2 → PAK2 (>>) |
| TK2 → PLA2R1 (>>) |
| TK2 → PPAP2A (>>) |
| TK2 → RASSF1 (>>) |
| TK2 → SEH1L (>>) |
| TK2 → SLC25A37 (>>) |
| TK2 → TK1 (>>) |
| TK2 → TM4SF1 (>>) |
| TK2 → UBE2C (>>) |
